http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6980331

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 3444s
issn 0008-5472
issueIdentifier 8 Suppl
pageRange 3442s-3444s
publicationName Cancer research
startingPage 3442s
bibliographicCitation Nagel GA, Wander HE, Blossey HC. Phase II study of aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer. Cancer Res. 1982 Aug;42(8 Suppl):3442s–3444s. PMID: 6123383.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_517f9907f4218edc7652f96e83f5d176
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_46f5aec01c221886337cf49401f914e9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6bf1f75374b6f47b710a410ec2cb4ab7
date 198208
identifier https://pubmed.ncbi.nlm.nih.gov/6123383
isPartOf https://portal.issn.org/resource/ISSN/0008-5472
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2786
language English
source https://pubmed.ncbi.nlm.nih.gov/
title Phase II study of aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer
discusses http://id.nlm.nih.gov/mesh/M0013279
http://id.nlm.nih.gov/mesh/M0008977
http://id.nlm.nih.gov/mesh/M0000499
http://id.nlm.nih.gov/mesh/M0000944
http://id.nlm.nih.gov/mesh/M0010707
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000616Q000008
http://id.nlm.nih.gov/mesh/D008525Q000008
http://id.nlm.nih.gov/mesh/D001943Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D004359
http://id.nlm.nih.gov/mesh/D000616Q000009
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D003863Q000139
http://id.nlm.nih.gov/mesh/D004341
http://id.nlm.nih.gov/mesh/D005723Q000097
http://id.nlm.nih.gov/mesh/D004334
http://id.nlm.nih.gov/mesh/D006854Q000097
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D005221Q000139
http://id.nlm.nih.gov/mesh/D008525Q000009
http://id.nlm.nih.gov/mesh/D001835Q000187
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000324Q000097
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2145
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.3.2.2
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5754
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6989
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3bb733e68167987b2ae5e37a44515995
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7660
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6279
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7428
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53786776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53789675

Total number of triples: 54.